Recently we developed an enzyme immunoassay involving the use of steroid -isomerase (EC 5.3.3.1) as enzyme label and exclusion-affinity chromatography for rapid separation of free antigen-enzyme conjugate that bound to antibodies (J. Immunol. Methods 35: 267-284, 1980). Here we describe an automated version of this procedure, for immunoassay of progesterone and choriomammotropin (human placental actogen) in serum with the use of a centrifugal analyzer. After incubation, suitable dilutions of sera or extract plus antiserum, conjugate, and double antibody were filtered on an estradiol affinity gel-filtration column; the enzyme activity of the filtrates was determined with the centrifugal analyzer. Results correlate well with those obtained by radioimmunoassay: r (progesterone) = 0.980, r (choriomammotropin) = 0.940. The within-run and between-run precision, specificity, sensitivity, accuracy, and speed of this system make it a useful tool for immunoassay.
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In recent years, enzyme-linked immunosorbent assays have been widely used for determination of steroid hormones (1-2) and protein hormones (3) (4) in serum. Peroxidase and f3-galactosidase are the enzymes usually used to label the antigens. In all cases, enzyme activity bound to immobilized antibodies requires an incubation with the substrate; therefore, kinetic studies could not be performed.
We have described (5, 6) an enzyme immunoassay in which steroid i-isomerase (EC 5.3.3.1) from Pseudomonas testosteroni was the enzymatic marker and exclusion-affinity chromatography was used for separating antigen-enzyme-antibody complexes (free and bound fractions). Because enzyme activity was determined directly in the bound fraction eluting from the chromatography column, a centrifugal analyzer could be used for this last step.
Here we present an enzyme immunoassay for progesterone and choriomammotropin (human placental lactogen; HPL) in which we use a CentrifiChem 400 centrifugal analyzer. Results compare favorably with those by radioimmunoassay. 
Materials and Methods

Reagents
Commercially obtained reagents:
Bovine serum albumin and S-acetylmercaptosuccinic anhydride were from Sigma Chemical Co., Saint Louis, MO 63178; glutathione and cyanogen bromide were from Fluka AG, Buchs, Switzerland; Ultrogel AcA 44 from Reactifs I.B.F., Villeneuve-laGarenne, France; progesterone from Roussel-Uclaf, Paris, France; mineral salts and solvents were from Merck, Darmstadt, F.R.G.; steroid -isomerase ("5,3-ketosteroid isomerase"), progesterone antiserum, and sheep antirabbit y-globulin serum from the Institut Pasteur Production, Marnes La Coquette, France; and HPL from U.C.B-Bioproducts, Bruxelles, Belgium.
Antibody prod uction: High-affinity antiserum to HPL was produced by subcutaneous multi-site injection of HPL into three New Zealand White female rabbits: 1 mg of the hormone in 1 mL of Freund's adjuvant, followed by an intradermal injection of 0.1 mg of hormone after four weeks, and 50 g intravenously two months later. Blood was collected by cardiac puncture 10 days after the last injection. Antisera was diluted 4000-fold in the enzyme immunoassay. Cross reactivity with human choriogonadotropin was 7%
and with prolactin 1%.
Antigen-enzyme conjugate:
The steroid -isomerase was thiolated with S-acetylmercaptosuccinic anhydride and coupled to progesterone and HPL as described elsewhere (5).
Glutathione-estradiol adsorbent:
We incubated 143 mg of 17/3-bromoacetoxyestradiol, prepared as described by Pons et al. (7) and dissolved in 30 mL of methanol, with 100 mg of gluthathione in 50 mL of carbonate buffer (0.1 m#{243}lIL, pH 9), for 6 h at room temperature.
Then we reacted the mixture with 60 mL of Ultrogel AcA 44 (R#{233}actifs IBF) activated by cyanogen bromide as described elsewhere (6).
Enzyme substrate:
We prepared A5-diketo-3,17-androstene by oxidation of dehydroepiandrosterone with Jones' reagent (8) .
Instrumentation
The CentrifiChem 400 centrifugal analyzer includes an analytical module controlled by a microprocessor and an automated sample reagent pipetting and dispensing system. At our request, this apparatus was kindly equipped with a deuterium lamp by Biosystem France-Union Carbide and Co, Silic 321, 94598 Rungis Cedex, France. Aliquots of samples (50 tL) and reagent (250 or 350 L) are loaded into their respective cavities of a 30-well Teflon transfer disk. This disk is placed in a cuvette rotor and rotated. Centrifu- gal force moves the liquids out into the rotor cuvettes, which pass through a stationary light beam. Therefore 30 separate reactions are initiated simultaneously and may be continuously monitored. We monitored the absorbance of the standards and unknown samples at 248 nm.
Procedures
Enzyme immunoassay.
Duplicate 100-tL aliquots of the diethyl ether extract of serum (for the progesterone assay) or of diluted serum (for the HPL assay) were pipetted into 10 x 45 mm disposable polypropylene tubes containing 100 L of the corresponding antisera and 100 .tL of diluted anti-rabbit y-globulin sera (400-fold final dilution). All dilutions were made with phosphate buffer (0.
Column eluates were placed in plastic cups sitting on the sample crown of the dispensing system. The sample reagents were loaded and the following volumes were transferred into the 
Results
Standard curve:
The variability between assays was not significant in different runs. The percentage of bound enzyme conjugate proportionately decreased as the concentration of unlabeled hormone increased from 0.15 to 10 g/L for progesterone and from 0.015 to 1 mg/L for HPL. The standard curves were plotted on log-logit paper.
Sensitivity:
In the standard curve plotted with every run, the percent bound for 0.07 (SD 0.01) pg of progesterone per liter and 3 (SD 0.5) pg of HPL per liter were significantly different at the 95% confidence limit from that for 0 pg of progesterone and HPL.
Reproducibility: 
Accuracy:
In analytical-recovery experiments, a reflection of accuracy, progesterone (0.3 to 5 pg/L) and HPL (0.7 to 5 mg/L) were added to pooled plasma from men, containing neither of these hormones. The correlation between "found" (y) vs "expected" (x) was good: for progesterone: y 1.028x + 0.17, r = 0.999; for HPL: y = 1.17x + 1.37, r = 0.991.
Parallelism:
Samples having high hormone concentrations were diluted and assayed. Plots of"plasma dilution" vs "found hormone" were linear and correlated well (Figure 1 ): r (progesterone) = 0.997, r (HPL) = 0.993.
Comparability:
We compared results by enzyme immunoassay (y) with those by the radioimmunoassay method (x) for HPL (80 samples) and progesterone (40 samples).
Linear regression gave the following results: for progesterone, y = 1.06x -0.25, r = 0.980, p < 0.001; for HPL, y = 1.08x -0.37, r = 0.940; p < 0.001.
Discussion
Here, all reactions take place in solution, which avoids difficulties resulting from adsorption of substrate and (or) product into insoluble material. Bound and free analyte are easily separated with a minimum of instrumentation.
Moreover, the adsorbent is regenerated by washing with water and may be used more than 100 times. The enzyme activity bound by the antibodies is determined directly in the effluent and steroid z-isomerase is assayed by following the formation of the chromophore at 248 nm in 1 or 2 mm, which eliminates errors from interfering absorbances by biological fluids. Results are obtained in less than 2 h.
In the present system the sensitivity was adjusted to 0.5 pg/L for progesterone and to 5 mg/L for HPL. These sensitivities can be increased, but this is not really necessary for this type of assay because of the concentration of these two hormones in women's plasma. The within-and betweenassay CVs did not exceed 10%, and we detected no systematic error in the procedure. Results of the recovery studies and of the parallelism test were satisfactory. Results by the enzyme immunoassay compared well with those by the radioimmunoassay method. Interference from serum protein is negligible, as demonstrated by the dilution tests.
The high reliability of the assay method is demonstrated by experimental results obtained here with a centrifugal analyzer in immunoassay of two different hormones: steroid and protein. We believe this method may be applicable to many ligand assay systems.
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